Aug 10, 2020 | Government Investigations, White Collar Crime
On August 6, 2020, the United States Attorney’s Office for the Northern District of Georgia announced that it had charged a Georgia businessman with “hoarding and price gouging” in violation of the Defense Production Act of 1950 (DPA). According to the government’s...
Aug 6, 2020 | COVID-19 Related Law, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid
On August 4, 2020, the Office of Inspector General for the United States Department of Health and Human Services (OIG) updated its FAQs regarding the application of OIG’s administrative enforcement authorities to arrangements directly connected to the ongoing COVID-19...
Aug 4, 2020 | False Claims Act, Government Investigations
On July 30, 2020, United States Senator Charles Grassley announced that he intends to introduce legislation which would strengthen the federal False Claims Act (FCA). Grassley indicated that his proposed legislation would, at least in part, specifically address the...
Jul 30, 2020 | COVID-19 Related Law, Government Investigations, Health Care, Medicare and Medicaid
On March 27, 2020, President Trump signed into the law the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The CARES Act includes a Provider Relief Fund (“PRF”) with more than $100 billion to reimburse eligible providers for healthcare-related...
Jul 6, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid
On June 26, 2020, the Eleventh Circuit Court of Appeals reinstated part of a $348 million verdict awarded pursuant to the False Claims Act (FCA). The court also held that a qui tam plaintiff may have standing to bring an FCA claim even after entering into a litigation...
Jul 2, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid
On July 1, 2020, the U.S. Department of Justice (“DOJ”) announced two separate settlements with Novartis Pharmaceuticals Corporation (“Novartis”), totaling more than $729 million, involving allegations that Novartis paid kickbacks to doctors and patients. In the first...
